Molecular mechanism by which gamma-herpesviruses evade autophagy
Molecular mechanism by which gamma-herpesviruses evade autophagy
批准号:
7449112
负责人:
Sangita Sinha
金额:
$23.55万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2009-07-31
关键词:
Acquired Immunodeficiency SyndromeAffinityAmino Acid SequenceApoptosisApoptoticAutophagocytosisBH3 DomainBindingBiochemicalBiological AssayCell DeathCell physiologyCellsComplexCultured CellsDataDefense MechanismsDown-RegulationEpithelialEpitopesFutureGoalsGrantHerpesviridaeHerpesviridae InfectionsHerpesvirus Type 3Homologous GeneHost Defense MechanismHumanHuman Herpesvirus 4Human Herpesvirus 8Immunocompromised HostIndividualInfectionInfectious MononucleosisKaposi SarcomaLymphoidMalignant NeoplasmsMeasurementMediatingMembraneModelingMolecularMurine herpesvirus 68MutagenesisOrganellesPathogenicityPatientsPharmaceutical PreparationsProteinsProto-Oncogene Proteins c-bcl-2Public HealthPurposeReagentResearchRoleSimplexvirusSiteSpecificityStructureSurfaceTechniquesTestingTherapeuticTissuesTransplant RecipientsVesicleViralViral PathogenesisVirusbasedesignin vivoinhibitor/antagonistmimeticsmutantnovel therapeuticspathogenpreventpro-apoptotic proteinprotein aggregatescaffoldsmall moleculethree dimensional structuretumor
中文摘要
描述(由申请人提供):3-疱疹病毒科包括广泛的、重要的人类病原体,如引起传染性单核细胞增多症和淋巴组织和上皮组织恶性肿瘤的eb病毒和导致卡波西肉瘤肿瘤的卡波西肉瘤病毒,特别是在艾滋病患者和移植接受者等免疫功能低下的个体中。3-疱疹病毒编码抗凋亡细胞Bcl-2蛋白(c-Bcl-2)的同源物,可能通过阻断细胞死亡来促进病毒的繁殖和致瘤性。抗凋亡的Bcl-2同源物阻止细胞凋亡的关键机制是通过隔离促凋亡的Bcl-2同源物。虽然病毒Bcl-2 (v-Bcl-2)和c-Bcl-2同源物序列同源性很低,但它们具有非常相似的三维结构。先前的结构、生化和诱变分析表明,抗凋亡Bcl-2同源物(包括大多数v-Bcl-2同源物)表面的疏水沟结合促凋亡Bcl-2同源物的两亲性BH3螺旋结构域。尽管有这种共同的BH3结构域结合机制,但由于氨基酸序列的差异,不同的Bcl-2同源物对不同的BH3结构域表现出独特的特异性。3-疱疹病毒也被证明可以抑制自噬,这是一个重要的细胞过程,细胞器、大蛋白聚集体、稳定蛋白以及细胞内病原体被包裹在双膜囊泡中,并被溶酶体降解。自噬通常由c-Bcl-2同源物与关键自噬效应蛋白Beclin 1的相互作用调节,而3-疱疹病毒自噬的下调是由v-Bcl-2同源物与Beclin 1的相互作用介导的。最近,Beclin 1也被证明含有BH3结构域,该结构域构成了与Bcl-XL和其他c-Bcl-2同源物结合的主要决定因素。我们的初步数据表明,Beclin 1与BH3结构域相邻的其他区域也参与了与Bcl-2同源物的相互作用。此外,各种c-和v-Bcl-2同源物结合在Beclin 1上重叠但不相同的位点上。这项资助的目的是描述Beclin 1与v-Bcl-2和c-Bcl-2同源物相互作用的差异,并验证其相似性。相互作用将首先通过结合亲和力的生化测量来量化。结构测定和分析将提供每个相互作用的细节,确定关键的特异性决定因素,这将通过量化所选突变体的结合亲和力来确认。最后,ABT737,一种抑制某些c-Bcl-2同源物和BH3结构域结合的肽模拟物,将被测试其破坏v-Bcl-2同源物和Beclin 1相互作用的能力。因此,这项研究将更好地了解疱疹病毒致病性的分子机制、细胞自噬过程、疱疹病毒与宿主蛋白之间的相互作用,以及如何通过诱变或小分子抑制剂选择性地修饰这些相互作用的信息,从而为进一步研究以及设计潜在的治疗方法来治疗这一医学上重要的病原体群体提供帮助。公共卫生相关性:重要的3-疱疹病毒人类病原体包括EBV和KSHV,前者可引起传染性单核细胞增多症和淋巴组织和上皮组织的恶性肿瘤,后者可引起卡波西肉瘤,特别是在艾滋病患者和移植接受者等免疫功能低下的个体中。这些病毒已经进化到下调自噬,这是一种已知的宿主防御机制,可以降解许多病原体。本应用程序旨在研究3-疱疹病毒抑制自噬机制的原子细节,从而更好地了解3-疱疹病毒的致病性。
英文摘要
DESCRIPTION (provided by applicant): The 3-herpesviridae includes widespread, important human pathogens like Epstein-Barr virus which causes infectious mononucleosis and malignant tumors of lymphoid and epithelial tissues and Kaposi Sarcoma virus, which causes Kaposi sarcoma tumors, especially among immunocompromised individuals such as AIDS patients and transplant recipients. 3-Herpesviruses encode homologs of the anti-apoptotic, cellular Bcl-2 protein (c-Bcl-2), presumably to facilitate viral propagation and oncogenicity by blocking cell death. A key mechanism by which anti-apoptotic Bcl-2 homologs prevent apoptosis is by sequestering pro-apoptotic Bcl-2 homologs. Although viral Bcl-2 (v-Bcl-2) and c-Bcl-2 homologs share very low sequence identity, they have very similar three-dimensional structures. Previous structural, biochemical and mutagenic analyses showed that a hydrophobic groove on the surface of anti-apoptotic Bcl-2 homologs, including most v-Bcl-2 homologs, binds the amphipathic BH3 helical domains of pro-apoptotic Bcl-2 homologs. Despite this shared general mechanism for binding BH3 domains, the different Bcl-2 homologs show unique specificity toward various BH3 domains, arising from differences in their amino acid sequences. 3-herpesviruses have been shown to also inhibit autophagy, a vital cellular process by which organelles, large protein aggregates, stable proteins, as well as intracellular pathogens are enclosed in double-membrane vesicles and targeted for lysosomal degradation. Autophagy is normally modulated by the interaction of c-Bcl-2 homologs with a key autophagy effector protein, Beclin 1, and the down-regulation of autophagy by 3-herpesviruses is mediated by the interaction of v-Bcl-2 homologs with Beclin 1. Recently, Beclin 1 was also shown to contain a BH3 domain that constitutes the primary determinant of binding to Bcl-XL and other c-Bcl-2 homologs. Our preliminary data indicates that additional regions of Beclin 1 contiguous with the BH3 domain are also involved in interaction with Bcl-2 homologs. Further, the various c- and v-Bcl-2 homologs bind to overlapping, but not identical, sites on Beclin 1. The goal of this grant is to characterize the differences and also to verify the similarities, in the interaction of Beclin 1 with v-Bcl-2 and c-Bcl-2 homologs. Interactions will first be quantified by biochemical measurements of binding affinity. Structure determination and analyses will provide details of each interaction, identifying key specificity determinants, which will be confirmed by quantifying binding affinity of selected mutants. Finally, ABT737, a peptido-mimetic that inhibits binding of certain c-Bcl-2 homologs and BH3 domains, will be tested for its ability to disrupt the interaction of v-Bcl-2 homologs and Beclin 1. Thus, this research will provide a better understanding of the molecular mechanisms of herpesvirus pathogenicity, the cellular process of autophagy, the interaction between herpesviral and host proteins, and information on how to selectively modify these interactions either by mutagenesis or by small molecule inhibitors, both for the purposes of further research as well as for designing potential therapeutics to treat this medically important group of pathogens. PUBLIC HEALTH RELEVANCE: Important 3-Herpesviruses human pathogens include EBV, which causes infectious mononucleosis and malignant tumors of lymphoid and epithelial tissues, and KSHV, which causes Kaposi sarcoma tumors, especially among immuno-compromised individuals such as AIDS patients and transplant recipients. These viruses have evolved to down-regulate autophagy, a host defense mechanism known to degrade numerous pathogens. This application aims to investigate atomic details of the mechanism by which 3-herpesviruses inhibit autophagy, providing a better understanding of 3-herpesviral pathogenicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanism by which Epstein-Barr Virus-encoded BHRF1 blocks BECN1-mediated autophagy
-
批准号:10797685
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2022
-
负责人:Sangita Sinha
-
依托单位:
Molecular mechanism by which Epstein-Barr Virus-encoded BHRF1 blocks BECN1-mediated autophagy
-
批准号:10439285
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2022
-
负责人:Sangita Sinha
-
依托单位:
Intrinsically Disordered Regions in Autophagy Proteins
-
批准号:8896892
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2014
-
负责人:Sangita Sinha
-
依托单位:
Intrinsically Disordered Regions in Autophagy Proteins
-
批准号:8773287
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2014
-
负责人:Sangita Sinha
-
依托单位:
COBRE: NDSU: PROJECT 5: NEW INVESTIGATOR
-
批准号:8360598
-
项目类别:
-
资助金额:$11.09万
-
财政年份:2011
-
负责人:Sangita Sinha
-
依托单位:
COBRE: NDSU: PROJECT 5: NEW INVESTIGATOR
-
批准号:8167865
-
项目类别:
-
资助金额:$11.23万
-
财政年份:2010
-
负责人:Sangita Sinha
-
依托单位:
Molecular mechanism by which gamma-herpesviruses evade autophagy
-
批准号:8015462
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2008
-
负责人:Sangita Sinha
-
依托单位:
海外基金